Skip to content

Vitamin D and Adipose Tissue: a Complex Relationship

Vitamin D and Adipose Tissue: Storage or Sequestration

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05957692
Acronym
ADIPOVITAD
Enrollment
58
Registered
2023-07-24
Start date
2020-01-01
Completion date
2022-12-31
Last updated
2023-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypovitaminosis D

Keywords

vitamin D, ultrasound, adipose tissue, storage

Brief summary

The goal of this observational study is to verify the role of adipose tissue in determining the vitamin D serum level after monthly oral administration in subjects with vitamin D deficiency. The main questions it aims to answer are: * Adipose tissue represents a storage environment for vitamin D or it's an environment where vitamin D is sequestered and no longer released * On the other hands, it's possible to verify whether the adipose tissue carries out a bi-modal activity towards vitamin D * If adipose tissue exerts a bi-modal effect, it is possible to identify a specific threshold between the two effects Participants will undergo anthropometric measurements (height, weight, waist/hip ratio waist circumference) at baseline and after 6 months of intake of cholecalciferol 50,000 IU/month

Detailed description

Vitamin D deficiency and insufficiency are prevalent worldwide, and various factors contribute to their occurrence, including low sun exposure, poor dietary intake, obesity, and abdominal obesity. Abdominal obesity, assessed by waist circumference (WC), is associated with metabolic syndrome and has been linked to low vitamin D levels. This study aimed to investigate the relationship between visceral adipose tissue (VAT) and vitamin D levels, particularly examining the potential threshold for vitamin D storage and sequestration by adipose tissue. The study is conducted on patients with hypovitaminosis D in an internal medicine outpatient department. Blood samples for the evaluation of calcium and vitamin D levels are collected at baseline and after six months of monthly cholecalciferol supplementation. Ultrasonography are used to evaluate adipose tissue measurements, including subcutaneous adipose tissue thickness, VAT, preperitoneal adipose tissue (PPAT), and prerenal adipose tissue (PRAT). Anthropometric measures such as waist-to-hip ratio and waist-to-height ratio are also assessed.

Interventions

None listed

Sponsors

Azienda Ospedaliera Universitaria Integrata Verona
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years

Inclusion criteria

* Vitamin D level \< 20 ng/ml * BMI \> 24

Exclusion criteria

* Administration of vitamin D metabolites in the last year * Previous diagnosis of metabolic bone diseases * Previous diagnosis of endocrine diseases * Previous diagnosis of cancer

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline of weight at 6 months6 monthsweight expressed in Kg
Change from Baseline of vitamin D levels at 6 months6 monthsblood sample expressed in ng/ml
Change from Baseline of height measurements at 6 months6 monthsheight expressed in cm
Change from Baseline of ultrasound adipose tissue measurement at 6 months6 monthsvisceral, subcutaneous, pre-renal, pre-peritoneal adipose tissue expressed in millimeters
Change from Baseline of waist and hip circumference at 6 months6 monthswaist and hip circumference expressed in centimeters
Change from Baseline of body adipose tissue at 6 months6 monthsbody adipose index expressed in percentage

Secondary

MeasureTime frameDescription
Change from Baseline of calcium levels at 6 months6 monthsblood sample expressed in mg/dl

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026